Conference News

Prof. Tanaka Masaru, Prof. Jinwei Zhang, Prof. Baojun Xu, etc. Will Be Present At ICBP2023!

ICBP2023 will be held in a more convenient online way on August 24, 2023. Prof. Tanaka Masaru, Prof. Jinwei Zhang, Prof. Baojun Xu, etc. will be present at ICBP2023!

Prof. Masaru Tanaka worked for TERUMO Co. and commercialized medical devices, such as artificial lung (Approved by FDA and Global market’s No.1 share). In 2000, he moved to Hokkaido University and in 2007 he moved to Tohoku University. He was a Visiting Scientist at Max-Planck-Institute (2008-2009). In 2009, he was awarded a full professorship at Yamagata University. Prof. Masaru Tanaka works as a full Professor at Kyushu University now. His research interests focus on the design of biocompatible soft-biomaterials for medical devices. He has published over 200 papers in peer reviewed journals (H-index 56), 50 book chapter, 125 others, more than 250 patents until now. Prof. Masaru Tanaka also received several awards, including the Japanese Society for Biomaterials Award, the SPSJ Asahi Kasei Award, and the British Council PMI2 Connect-Research Co-operation (UK) Award.

Dr. Jinwei Zhang is a Principal Investigator in Medicine at the University of Exeter Medical School, UK. Professor in Biomedical Science, Xiamen University Medical School, China. His laboratory studies ion channels, transporters, and signalling pathways that associated with human diseases, for examples, stroke that regulated by WNK SPAK/OSR1-KCC2/NKCC1, hypertension that regulated by WNK-SPAK/OSR1-NCC, and concern with elucidating and targeting ion transporters, kinases, protein-protein interactions using genetic mouse models, small molecules, CRISPR/Cas9 gene-editing technologies, and electrophysiology to aid discovery and validation of new potential drug targets. He is internationally recognized for his expertise in cellular chloride homeostasis and cell volume regulation and drug discovery. He has published more than 70 articles in journals including Cell, Nature Medicine, Cell Metabolism, Neuron, Nature Communications, EMBO molecular medicine, Science Signalling, Human Molecular Genetics etc. and has achieved more than 3150 citations, H-index=30, i10-index=45. His current research is supported by the NIH R01, The Royal Society UK, NSFC, Alzheimer's Research UK and Commonwealth Commission Funding etc. He is an Associate Editor for the Frontiers in Pharmacology, Frontiers in Microbiology, and Frontiers in Physiology, Editor in Chief for the Journal of Modern Biology and Drug Discovery. He is currently a member of the editorial boards of 40 scientific journals and completed editing >70 manuscripts, as well as a reviewer for more than 60 scientific journals and completed reviewing >100 manuscripts.

Dr. Baojun Xu currently is a Chair Professor and Ph.D Supervisor in BNU-HKBU United International College, Zhuhai Scholar Distinguished Professor, and Department Head of Life Sciences. His research interests include Hytochemicals, Nutraceuticals, Pharmaceuticals, Functional Foods, Molecular Nutrition, Cell Biology. He has published near 300 papers in international journals. Dr. Xu is the first authors or corresponding authors of over 290 peer-reviewed scientific papers (over 260 SCI papers). The papers published have been widely cited with a total of 15064 citations (Google Scholar), h-index at 62, i10-index at 184 (Google Scholar) and have SCI impact factor at a total of 1055.88. Eight papers were selected as ESI highly cited papers, two papers were selected as ESI hot papers. Dr. Xu is serving as Editor-in-Chief of Nutrition, Dietetics & Nutraceuticals, Associate Editor-in-Chief of Food Science and Human Wellness, Associate Editor of “Food Research International” and “Food Frontiers”, Co-Editor of The Open Bioactive Compounds Journal, and Guest Editor for 9 special issues in Current Opinion in “Food Science”, “Antioxidants”, “International Journal of Molecular Sciences” , “Molecules”, “Journal of Fungi” , and the editorial board member of around 10 international journals.